基本信息
文件名称:【高盛-2025研报】太阳制药工业(SUN):太阳制药工业公司(SUN.BO):宣布管理层变动.pdf
文件大小:248.82 KB
总页数:6 页
更新时间:2025-07-02
总字数:约3.95万字
文档摘要

16June2025|4:39AMIST

SunPharmaceuticalIndustries(SUN.BO):Announceschangesin

management

Whathappened?ShyamSrinivasan,CFA

+91(22)6616-9346|

SunPharmahasannouncedtheappointmentofMr.KirtiGanorkar(currentlyheadingshyam.srinivasan@

GoldmanSachsIndiaSPL

IndiabusinessatSun)astheManagingDirectortosucceedMr.DilipShanghvi,

KaranVora,CFA

effectiveSept1,2025,withtheentirebusinessandallfunctionsreportingtohim.+91(22)6616-9146|karan.vora@

GoldmanSachsIndiaSPL

ThisappointmentissubjecttoapprovaloftheshareholdersattheupcomingAGM.

Mr.Ganorkar’shistorywithSun:Mr.GanorkarhasbeenheadingIndiaBusinessat

SunPharmasinceJune2019.Previously,hehasheldvariousleadershiprolesacross

businessdevelopment,marketing,MA,newproductintroduction,project

management,IPandlitigationatSunPharma.HeplayedakeyroleindrivingSun

Pharma’sforayintospecialtybysecuringrightsforinnovativeproductssuchas

Ilumya.HehasalsoledSunPharma’sentryintoJapanandlaidinitialgroundworkfor

thecompany’sentryintoEurope,perthecompany.

Whatcoulditmeanforotherbusinessheads?

MrShanghviwillcontinuetochairtheBoardasExecutiveChairman.Hewillfocus

onstrengtheningSunPharma’sspecialtyportfolioand